Introduction better design agents that might prevent cofactor utilization by primary HIV strains. In addition, structureThe entry of HIV-1 into target cells requires the participafunction studies of HIV-1 cofactors will be needed to tion of at least two cell surface molecules. All HIV-1 understand the role these receptors play in viral entry strains utilize CD4 as the primary virus receptor through and membrane fusion. a high affinity interaction with the viral envelope (env) To identify regions in CCR5 that play a role in memprotein. However, CD4 alone is not sufficient for virus brane fusion mediated by a variety of M-tropic and dualentry: one or more additional cell surface molecules, tropic viruses, we constructed chimeric molecules termed cofactors, are required (Maddon et al., 1986;  based on CCR5 and CCR2b, the chemokine receptor to Ashorn et al., 1990; Chesebro et al., 1990; which CCR5 is most closely related (76% identity). We al., 1992; Broder et al., 1993) . Virus strains adapted for found that M-tropic viruses were most sensitive to growth in transformed T cell lines (T-tropic) use the changes in the very N-terminal portion of the amino-SDF-1 chemokine receptor as a cofactor (Feng et al., terminal domain and in the first extracellular loop. While substitution of either domain with the corresponding region of CCR2b was tolerated, substitution of both was not. We found several chimeric molecules that could function as cofactors for either M-tropic or dual-tropic env proteins, but not both. Our results identify regions in CCR5 required for cofactor function, indicate that interactions between CCR5 and M-and dual-tropic viruses can differ and are structurally complex, and suggest that the molecular evolution of virus strains for growth in a given target cell population may involve changes not only in the types of cofactors used, but also in how a given cofactor is utilized.
Results

The ␤-Chemokine Receptors CCR5 and CCR2b Support Fusion and Infection by Viruses with Distinct Tropisms
Introduction of CCR5 in conjunction with human CD4 into otherwise nonpermissive cells renders them fully permissive for M-tropic virus entry and for M-tropic envmediated syncytia formation. By contrast, expression of CCR2b fails to render cells permissive for M-tropic env-mediated syncytia formation Deng et al., 1996; Dragic et al., 1996) . between CCR5 and CCR2b. This approach had two im-(89.6) env proteins. Effector cells were also infected with vTF1.1 (MOI ϭ 10), which expresses T7 polymerase under the control of portant advantages. First, construction of chimeras bethe vaccinia late promoter. Cells were allowed to fuse for 6-8 hr tween two closely related molecules is more likely to before lysis in Reporter Lysis Buffer (Promega) and assay for luciferresult in proper folding and transport to the cell surface ase activity. Results are expressed in terms of relative light units (Doms et al., 1993) . Second, since 89.6 uses both cofac- , 1996) . In this assay, HeLa cells are infected with cofactor for virus infection. QT6 cells expressing CD4 recombinant vaccinia virus vectors expressing the env alone or in combination with CCR5 or CCR2b were inprotein of interest and the T7 RNA polymerase. Quail fected with either 89.6 or JR-FL. To detect virus entry QT6 cells are transfected with plasmids encoding CD4, 24 hr later, we used a PCR-based entry assay to detect the desired cofactor, and the luciferase gene under conearly viral DNA transcripts. We found that CCR2b suptrol of the T7 promoter. QT6 cells were chosen as targets ported entry by 89.6 but not by JR-FL ( Figure 1B ). Thus because expression of CD4 alone fails to render them CCR2b served as a fusion and infection cofactor for permissive for env-mediated membrane fusion and be-89.6 but not for the M-tropic strains tested here. cause they are easily transfected. Fusion between the target and effector cells results in T7 polymerase-dependent luciferase expression, making this a sensitive and
The N-Terminus of CCR5 Is Sufficient but Not quantitative cell-cell fusion assay. We found that HeLa Necessary for JR-FL env-Mediated Fusion cells expressing the env proteins derived from the To identify regions of CCR5 that are required for cofactor M-tropic strains JR-FL, ADA, and SF162, together with function, a series of chimeric molecules was generated the clade E strain CM243, readily fused with QT6 cells in which individual extracellular domains of CCR2b were expressing CD4 and CCR5 ( Figure 1A ). Fusion was not replaced with the corresponding regions of CCR5. In observed when either Fusin or CCR2b was used in place this way, we could determine whether any single region of CCR5. By contrast, the env protein derived from the of CCR5 could confer M-tropic cofactor activity to dual-tropic virus strain 89.6 formed syncytia with cells CCR2b. Chimeric molecules were created by utilizing expressing either Fusin, CCR2b, or CCR5 in conjunction with CD4, as previously reported . common restriction sites in regions conserved between with CD4 in QT6 cells and then mixed with HeLa cells expressing either the 89.6 or the JR-FL env proteins. As shown in Figure 2B , substitution of the amino-terminal domain and first transmembrane segment of CCR2b with the corresponding region of CCR5 resulted in a chimera that supported fusion by both the JR-FL and 89.6 env proteins. We also note that this chimera (C25-06) has no potential N-linked glycosylation sites, indicating that N-linked glycosylation is not required for cofactor function. Indeed, elimination of the N-linked glycosylation site in CCR5 by site-directed mutagenesis had no effect on cofactor function (data not shown). Replacement of the second or third extracellular loops of CCR2b with those from CCR5 failed to support JR-FL mediated membrane fusion. However, both of these chimeras (C25-14 and C25-03) supported fusion mediated by 89.6, indicating that they were expressed on the cell surface. One chimera, C25-10, failed to support fusion by either JR-FL or 89.6. Since the 89.6 env protein can fuse with cells expressing CD4 and either CCR5 or CCR2b, we think it most likely that this chimera is not expressed at the cell surface, perhaps due to a folding defect. Development of specific antisera will make it possible to measure surface expression of this and other chimeric molecules.
The results with the first set of chimeric molecules indicated that the amino terminus of CCR5, when introduced into a CCR2b background, was sufficient to confer M-tropic cofactor activity to CCR2b. To determine whether the amino-terminal domain of CCR5 was re- 
and JR-FL Cofactor Usage
To further delineate the region of the CCR5 amino terminus that is critical for cofactor function, we constructed the two molecules ( Figure 2A ). This approach also resulted in substitution of CCR2b transmembrane and cya series of CCR5 molecules containing sequential fouramino acid deletions after the N-terminal methionine toplasmic domains with those from CCR5. However, as shown in Figure 8 , the transmembrane domains of CCR5 ( Figure 3A ). We found that elimination of the first eight residues from the mature molecule (i.e., after the initiator and CCR2b are highly conserved (89% identity, including all seven proline residues), as are the three intracellumethionine) had no effect on JR-FL or 89.6 env-mediated syncytia formation ( Figure 3B ). However, removal lar loops (92% identity). Including highly conservative amino acid substitutions, the degree of similarity beof an additional four or eight residues blocked fusion by 89.6 but not by JR-FL. Thus 89.6 is more sensitive tween the transmembrane and intracellular loops of CCR5 and CCR2b is 95% and 96%, respectively. By to truncations in the amino-terminal domain of CCR5 than is the M-tropic strain JR-FL, indicating that different contrast, the extracellular domains of CCR5 and CCR2b share only 45% amino acid identity. Thus the aminoenv proteins can utilize the same cofactor in different ways. terminal domain and extracellular loops are likely to play the major role in determining the cofactor phenotypes Since regions of CCR5 other than the N-terminal domain can also allow fusion by JR-FL (Figure 3 ), we reaexhibited by the chimeric molecules.
The chimeras, depicted in Figure 2A , were expressed soned that truncations of the CCR5 amino terminus the first four residues of the CCR5 amino terminus; C25-22, lacking residues were deleted, respectively. The ability of each construct the first eight residues of CCR5; C25-28, in which the first 20 residues to support fusion for JRFL and 89.6, respectively, is shown above of CCR5 are in a CCR2b background; C25-25, in which the first 20 each construct in parentheses.
residues of CCR2b are in a CCR5 background; and C25-26, in which (B) Fusion of QT6 cells expressing CD4 and the indicated cofactor the first 20 residues of CCR5 are followed by the rest of the CCR2b or chimera with HeLa cells expressing the JR-FL or 89.6 env proteins amino-terminal domain, the first transmembrane domain of CCR2b, was determined using the luciferase reporter assay as shown in and the rest of CCR5. sayed on its normal, functionally redundant background. We therefore constructed a series of chimeric molecules in which the truncated amino-terminal domains of CCR5 play important roles in governing cofactor function, that the ability of JR-FL to utilize the CCR5 amino-terminal were placed into a CCR2b background ( Figure 4A ). Chimera C25-21, which contains the N-terminal domain of domain is dependent on amino acids 2-5, and that the ability of 89.6 to utilize the CCR5 amino-terminal domain CCR5 truncated by four residues in a CCR2b background, supported fusion by 89.6 but not by JR-FL is dependent upon residues 6-9 of CCR5. Further truncations of the CCR5 N-terminus on a CCR2b back-( Figure 4B ). This was somewhat surprising, since the identical truncation in a CCR5 background (C25-17) supground did not give rise to active cofactors (data not shown). ported fusion by both JR-FL and 89.6. Removal of an additional four residues (C25-22) abolished cofactor
To identify the minimal portion of the CCR5 amino terminus capable of conferring cofactor function to function for both 89.6 and JR-FL, even though the identical truncation in a CCR5 background (C25-18) supCCR2b, three additional chimeras were constructed ( Figure 4A ). We found that substitution of the first 20 ported fusion by both viral env proteins. While it is possible that chimera C25-22 may not be expressed on the residues of CCR2b with those from CCR5 (C25-28) supported fusion by both JR-FL and 89.6, while the reciprocell surface, we note that the truncation itself is tolerated (C25-18), making it more likely that C25-22 is delivered cal chimera containing the first 20 residues of CCR2b in a CCR5 background (C25-25) supported fusion by JRto the plasma membrane. Therefore, for both JR-FL and 89.6, N-terminal truncations that otherwise have no ef-FL alone ( Figure 4B ). The inability of C25-25 to support fusion by 89.6 was surprising, since chimera C25-01, fect on cofactor function in CCR5 actually prevent cofactor usage in a CCR2b background. These findings indiwhich contained the entire CCR2b amino terminus and first transmembrane domain in a CCR5 background, cate that regions other than the amino terminus of CCR5 substitution of either the amino-terminal domain or first extracellular loop of CCR5 with the homologous CCR2b regions, it cannot tolerate substitution of both. Thus, did support 89.6 fusion. These results show that, while in the presence of the CCR5 amino-terminal domain, complete substitution of the amino-terminal domain of multiple changes in the first, second, and third extracel-CCR5 with that from CCR2b is tolerated by both viruses, lular loops are well tolerated (C25-05, C25-13). partial domain substitutions within the amino-terminal Several chimeric molecules failed to support fusion by domain sometimes (C25-25), but not always (C25-26), either 89.6 or JR-FL, including C25-08, which contained fail to support fusion. Partial domain substitutions may both the amino-terminal domain and the first extracellualter the conformation of the amino-terminal domain or lar loop of CCR5. To determine whether these chimeric perhaps affect the way in which it interacts with the molecules were processed normally, we assessed their extracellular loops. glycosylation states. An antigenic tag corresponding to a sequence nine amino acids long and derived from influenza hemagglutinin (HA) was placed at the amino or The Role of Extracellular Loop Domains in Cofactor Function carboxyl terminus of CCR5, CCR2b, and three chimeric molecules that failed to support membrane fusion: C25-The chimeras described above implicated both the amino terminus of CCR5 as well as one or more addi-08, C25-12, and C25-11. The tagged versions of CCR5 and CCR2b supported membrane fusion by 89.6, inditional domains as playing important roles in cofactor function. In order to assess the contribution of other cating that they are transported to the cell surface. QT6 cells expressing the indicated receptor were lysed, and domains in CCR5 to cofactor function, chimeras containing multiple domain substitutions were constructed aliquots were digested with endoglycosidase F (endo F) to remove N-linked carbohydrate chains. Fusin-HA ( Figure 5A ). As shown in Figure 3B , we found that substitution of the CCR5 amino-terminal domain with that from was also examined, since we have previously shown that it contains at least one N-linked carbohydrate chain CCR2b did not affect cofactor function, even though several chimeric and mutant molecules (C25-06, C25- . We found that CCR2b was N-glycosylated (Figure 6 ), indicating that the single N-linked 19, C25-20, C25-21) clearly showed that the amino-terminal domain of CCR5 plays an important role in supconsensus site in the CCR2b amino-terminal domain is utilized. However, digestion of CCR5 with endo F failed porting env-mediated membrane fusion. However, we found that substitution of both the amino-terminal and to increase its mobility in SDS-PAGE, indicating that it or very similar fashion, but one that is distinct from the dual-tropic 89.6 strain.
Discussion
The entry of HIV-1 into target cells involves interactions with the primary virus receptor, CD4, and one or more cofactors (Broder et al., 1993; Alkhatib et al., 1996; Deng et al., 1996; Dragic et al., 1996; Feng et al., 1996) . The specific type of cofactor used is a major determinant of viral tropism. Thus, HIV-1 strains adapted for growth on transformed T cell lines use a seven-transmembrane domain receptor, Fusin ; Choe et al., ruses do not appear to play a significant role in virus transmission and often cannot be recovered from HIV-1 positive individuals. Instead, most primary virus isolates is not N-glycosylated. Chimeric molecules containing fail to infect transformed T cell lines, though they infect the CCR2b amino-terminal domain were N-glycosylated primary macrophages and primary T cells efficiently. as well. Migration of chimera C25-08 was not affected These M-tropic virus strains are responsible for sexual by endo F digestion, consistent with the fact that it does transmission of HIV-1 and are the prevalent virus type not contain N-linked consensus sequences.
isolated after seroconversion and during the asymptomTo determine whether the glycosylated receptors atic portion of the disease (Å sjö et al., 1986; Tersmette were processed normally, we subjected aliquots of cell et al., 1988 , 1989 Schuitemaker et al., 1991 Schuitemaker et al., , 1992 ; Roos lysates to digestion with endoglycosidase H (endo H).
et al., 1992; Conner et al., 1993) . With time, both dualWe found that both Fusin and CCR2b were largely resistropic and T-tropic viruses emerge in some individuals, tant to endo H digestion, indicating that both receptors with dual-tropic viruses perhaps representing an interwere transported through the Golgi apparatus. However, mediate phenotype (Tersmette et al., 1988 ; Collman et chimeras C25-12 and C25-11 were completely or largely al., 1992). sensitive to endo H digestion, suggesting that these Recently, CCR5, a chemokine receptor that binds molecules were not transported to the Golgi and cell RANTES, MIP-1␣, and MIP-1␤ (Samson et al., 1996) , has surface. Thus, the failure of C25-12 and C25-11 to supbeen shown to be the principle M-tropic virus entry port fusion by HIV-1 env proteins can be attributed to cofactor (Alkhatib et al., 1996; ; Deng a transport defect. It is interesting to note that, of the five et al. Dragic et al., 1996) . The chimeric molecules in this study that failed to function as identification of CCR5 as the major entry cofactor for entry cofactors, four contained the second extracellular M-tropic viruses was aided by its homology ‫)%03ف(‬ to loop of CCR2b, a region of the receptor that contains Fusin and by observations that RANTES, MIP-1␣, and an unpaired Cys residue not present in CCR5. Since MIP-1␤ are the major viral suppressive factors secreted unpaired Cys residues often form inappropriate disulfide by CD8 ϩ cells (Cocchi et al., 1995) and that lymphocytes bonds in the ER (Doms et al., 1993) , chimeric receptors from some exposed, uninfected individuals secrete high containing the second extracellular loop of CCR2b might levels of these chemokines (Dragic, 1996;  Paxton et be at greater risk for misfolding and retention in the ER. al., 1996) . Most M-tropic virus strains studied thus far appear to exclusively use CCR5 as an entry cofactor, though the number of virus strains for which cofactor Clade B M-Tropic Strains Utilize Similar CCR5 Domains usage has been studied is small, especially viruses from other clades. It is clear, however, that some virus isoOur studies indicated that the M-tropic env protein derived from JR-FL and the dual-tropic 89.6 env protein lates can use alternative chemokine receptors as entry cofactors . The exhibited differences in their abilities to utilize chimeric and mutant CCR5 molecules. To determine whether vidual-tropic strain 89.6 is remarkably promiscuous: in addition to CCR5, it can use Fusin and the chemokine rus strains with the same tropism also exhibited differences in their use of CCR5, two additional M-tropic receptors CCR3 and CCR2b as entry cofactors , suggesting that interactions between viviruses were tested for their abilities to utilize a subset of the chimeric molecules, including C25-01, C25-06, ruses and chemokine receptors will be dependent upon conserved, conformational elements. C25-21, C25-17, C25-18, and C25-19. As shown in Figure 7 , no differences were observed between the differIdentifying regions in CCR5 and other viral cofactors that are important for viral entry will be important for ent virus strains, indicating that the M-tropic viruses JR-FL, ADA, and SF162 interact with CCR5 in an identical understanding the molecular basis of viral tropism and The amino acid sequence of CCR5 is depicted. Extracellular Cys residues are indicated by bars, and the single N-linked glycosylation consensus site is indicated by an asterisk. Residues that are identical to those in CCR2b are indicated by dark shading, while highly conservative substitutions are indicated by light shading. The locations of the restriction sites used to generate the chimeric molecules are shown.
may assist in the design of novel antiviral compounds. important for cofactor activity, since the N-terminal domain of CCR5 could be replaced with the corresponding The approach we took to identify functionally important CCR5 domains involved the construction of chimeras region from CCR2b and still function as an M-tropic cofactor. As a consequence, changes in the CCR5 between CCR5 and CCR2b and mutagenesis of the CCR5 amino-terminal domain. CCR2b is expressed in amino-terminal domain that might otherwise affect cofactor function might go unobserved when assayed on monocytes, binds the CC chemokines MCP-1 and MCP-3 (Charo et al., 1994; Franci et al., 1995) , and shares the functionally redundant CCR5 background. Indeed, additional complexities were observed when CCR5 76% amino acid identity with CCR5. Due to their structural similarity, we anticipated that a high proportion amino-terminal mutations were examined in a CCR2b background. Thus the ability of M-tropic env proteins of chimeras generated between these two molecules would be transported to the cell surface. In fact, at least to use CCR5 was dependent on residues 2-5 of the N-terminal domain, while 89.6 was strongly dependent 18 of the 24 chimeric and mutant molecules studied here were expressed on the cell surface as judged by on residues 6-9. Therefore, the amino-terminal domain of CCR5 plays an important role in cofactor function their ability to support env-mediated membrane fusion. A further advantage of using CCR2b as a template for for both M-and dual-tropic viruses, though there are differences in how each virus type utilizes this domain. studying functionally important CCR5 domains is that it is used by 89.6 as an entry cofactor, making it likely that Our results also implicate the first extracellular loop of CCR5 as being important for cofactor function, although most chimeric molecules would function as cofactors for this viral env protein. We found four chimeric or like the amino-terminal domain it is not absolutely necessary: the first loop of CCR5 can be replaced by the mutant receptors that functioned for 89.6 but not for JR-FL and three that functioned for JR-FL but not for corresponding region in CCR2b without loss of activity. The 14-residue-long first extracellular loop contains a 89.6. Thus we were able to detect functional cofactors that would have been scored as negative had we used conserved Cys residue thought to form a disulfide bond with a Cys residue in the second extracellular loop, along only one type of env protein. Finally, the transmembrane and cytoplasmic loops of CCR5 and CCR2b are highly with three charged residues, none of which are conserved between CCR5 and CCR2b. Chimera 25-02 is the conserved (95% and 96% including highly conservative substitutions, respectively), whereas the extracellular most informative with regards to the potential function of this domain. Replacement of both the amino-terminal domains share only 45% amino acid identity (Figure 8 ). Thus the extracellular domains are likely to play the domain and the first extracellular loop (C25-02) resulted in a chimeric molecule that could be used by 89.6 but major role in determining the cofactor phenotypes exhibited by the chimeric molecules.
not by M-tropic viruses as a fusion cofactor. By contrast, double substitution of the first and second loops (chiOur results indicate that the amino terminus of CCR5 plays an important role in virus entry. The amino-terminal mera C25-05) or the first and third loops (C25-13) of CCR5 with those from CCR2b was tolerated, as long domain of CCR5 was the only region that, when introduced into CCR2b, conferred M-tropic cofactor activity as the CCR5 amino-terminal domain was present. We found that M-tropic viruses could tolerate substitution to the resulting chimera. Further analysis showed that the first 20 residues of CCR5, the region of CCR5 that of either the N-terminal domain or the first extracellular loop of CCR5 with the corresponding CCR2b domains is most highly divergent from CCR2b (Figure 8 ), were sufficient for conferring M-tropic cofactor activity to but not of both simultaneously.
We also constructed chimeras to test the role of the CCR2b. However, other regions of CCR5 must also be second and third extracellular loops in cofactor function.
that relatively subtle changes in chemokine structure can result in a different receptor-binding profile. SubstiThe second extracellular loop is highly divergent between CCR5 and CCR2b, with only 11 of 30 residues tution of Leu-25 in IL8 with Tyr enables this CXC chemokine to bind to the CC chemokine receptor CCR1 (Lustibeing conserved, including a Cys residue and three sequential charged amino acids. Introduction of the sec- Wells et al., 1996) , while deletion of the RANTES amino terminus enables it to bind to ond loop from CCR5 into CCR2b failed to confer M-tropic cofactor function, while substitution of the secmultiple chemokine receptors (Gong et al., 1996) . Although the identification of multiple functionally imporond loop of CCR5 with that from CCR2b failed to prevent M-tropic env-mediated membrane fusion. Thus, the sectant regions in CCR5 for cofactor activity suggests that structurally complex interactions may occur between ond loop appears to play little role in cofactor specificity, at least when tested in either a CCR5 or CCR2b back-CCR5 and M-tropic viruses, relatively minor changes in env structure could result in altered coreceptor utilizaground. However, we cannot rule out the possibility that residues conserved between CCR5 and CCR2b particition that would be important for virus evolution. Further mutagenesis studies will aid in better defining the critical pate in some way.
The third extracellular loop is the most highly condeterminants for cofactor activity and assist in the design of novel antiviral compounds that may be capable served ectodomain region between CCR5 and CCR2b, with 17 of 23 residues being identical, including all four of blocking both M-and dual-tropic isolates. charged residues. Since introduction of the third extraExperimental Procedures cellular loop of CCR5 into a CCR2b background was not sufficient for M-tropic cofactor activity (C25-03), these CCR5/CCR2b Hybrid Constructs conserved residues by themselves are clearly not suffiThe CCR5 construct has been described previously (Samson cient for cofactor function. However, due to their similar- et al., 1996) . The coding region of CCR2b was amplified by PCR ity, the fact that replacement of CCR5's third loop with using NTerm2 (5Ј-TCGAGGATCCACAACATGCTGTCCACA-3Ј) and that from CCR2b had no effect on cofactor function Cterm2 (5Ј-CTGATCTAGACCTCGTTTTATAAACCAG-3Ј) as primers and cloned between the BamHI and XbaI sites of pcDNA3. The AflII should not be taken as evidence that this region is not high degree of conservation of this region, the use of (5Ј-AGCCAGGTACCTATCGATTGTCAG-3Ј) for CCR5, and Nterm2 and Afl2R2 (5Ј-AGTCAAGCACTTAAGCTTTTTGCAG-3Ј) as well as both receptors as cofactors by 89.6 (Doranz et al., 1996) , Afl2F2 (5Ј-CTGCAAAAAGCTTAAGTGCTTGACT-3Ј) and Cla1R for and studies with the IL8 receptor (Hebert et al., 1993;  CCR2b. Products were cleaved by either BamHI and AflII or AflII Horuk, 1994) all suggest that residues in the third loop in this area is that the N-terminus of these molecules plays a major role in specificity and function. The amino Deletion Mutants terminus of the Duffy antigen, a receptor that binds both
The deletion mutants of the CCR5 N-terminal extracellular region CC and CXC chemokines, plays a critical role in ligand (C25-17 to C25-20) were constructed by generating PCR fragments, binding (Zhao-hai et al., 1995) , and the N-terminal region using Afl2R5 as common reverse primer and N5D4 (5Ј-TCGAGGATC of the IL8 receptor is a major determinant in defining CAAGATGTCAAGTCCAATCTAT-3Ј), N5D8 (5Ј-TCGAGGATCCAAGA TGTATGACATCAATTAT-3Ј), N5D12 (5Ј-TCGAGGATCCAAGATGTAT ligand specificity (Hebert et al., 1993; Horuk, 1994; Ahuja TATACATCGGAG-3Ј), and N5D16 (5Ј-TCGAGGATCCAAGATGGAGC et al., 1996) . Alanine-scanning mutagenesis of IL8-RA CCTGCCAAAAA-3Ј), respectively, as forward primers. The PCR identified three charged residues important for ligand products were cleaved with BamHI and AflII and cloned into the binding, including two in the third extracellular loop of CCR5 construct cleaved with the same enzymes. Amplified segthe receptor (Hebert et al., 1993) . The amino-terminal ments were verified by sequencing. The deleted CCR5 N-terminal domains of Fusin and CCR5 also segments were transferred onto the CCR2b background (C25-21 to C25-24) by cloning BamHI/AflII fragments into the pcDNA3-CCR2b appear to be important for HIV env fusion activity. Howconstruct. ever, as is the case for the IL8 receptor, our findings indicate that multiple regions of CCR5 are important for
Other Constructs
HIV env cofactor activity, including the N-terminus and N-and C-terminally tagged constructs were made by PCR incorpofirst extracellular loop. The involvement of multiple exration of the 12CA5 epitope of the influenza hemagglutinin protein tracellular domains of CCR5 in virus entry is not surpris- (HA) . N-terminal tagging of CCR5 involved the use of the NTag5 ing. By analogy with other seven transmembrane doforward primer (5Ј-TCGAGGATCCAAGATGTACCCCTACGACGTG CCCGACTACGCCGGGCCCGGGGATTATCAAGTGTCA-3Ј), insertmain receptors, conserved disulfide bonds (Figure 8) ing the peptide YPYDVPDYAGPG immediately after the initial methiare likely to bring the extracellular domains of CCR5 in onine, and the Afl2R5 reverse primer. The PCR product was cleaved close proximity to one another (Horuk, 1994; by EcoRI and AflII and cloned into the pcDNA3-CCR5 construct.
1994).
The HA tag was also introduced at the C-terminus of both CCR5
We have shown a distinction between M-and dualand CCR2b, using a similar approach.
tropic HIV virus strains in their use of CCR5 as a fusion
The CCR5/CCR2b N-terminal hybrids (C25-26 and C25-28) were constructed using the Nterm5 and N5>2R1 (5Ј-TCAAATTTATGACA cofactor. Studies with several chemokines have shown
